Novartis (NOVN: VX) has reported new data showing that its investigational BTK inhibitor, remibrutinib, significantly ...

US biotech Amgen (Nasdaq: AMGN) and Japanese partner Kyowa Kirin (TYO: 4151) announced new results from the ongoing ROCKET ...

Flagship Pioneering-founded Valo Therapeutics says it has successfully secured a financing round of 19 million euros ($20.6 million), part of which was raised in Europe and part in Australia, to ...

The Bulgarian Association of Research-Based Pharmaceutical Manufacturers, ARPharM, says it is following the discussion of the ...